Loading clinical trials...
Loading clinical trials...
B2611003 is designed to study how safe and effective an investigational medication (PF-04991532) is in people with Type 2 diabetes. Subjects in the study will receive 1 of 6 treatments for 3 months. O...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT07112339 · Diabetes Mellitus, Type 2
NCT06329375 · Diabetes Mellitus, Type 2, Food Insecurity, and more
NCT06945406 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
NCT06959901 · Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention
Pfizer Investigational Site
Little Rock, Arkansas
Pfizer Investigational Site
Roseville, California
Pfizer Investigational Site
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions